Contact info
- Phone
- 1-866-706-2400
- Fax
- 1-866-470-1748
Eligibility
- To apply, please visit the program interactive forms at: Pfizer PAP Connect
- The Pfizer Patient Assistance Program provides eligible patients with select Pfizer medicines for free. To qualify:
- Note: Commercially insured patients are not eligible for the PAP, regardless of their income status or medicine's formulary status.
- Patients must meet program income guidelines, which vary by product and household size.
- Medicines accessed through the PAP must be for an FDA approved indication.
- Patients must reside in the US or any of the US territories.
- Income limit, single
- Not published
- Income limit, couple
- Not published
- Other income rules
- Income varies by medication needed.
- Adjusted for family size.
- NOTE: If patient has no income and does not file taxes, a letter from the physician stating the patient has no income OR a notarized letter from a family member is required.
- Medical expenses can be deducted
- Not published
- Social Security number asked for
- No
- US citizenship or residency required
- Yes
Not sure where your income falls? See this year's federal poverty guidelines (opens in a new tab).
Application process
- Documents to attach
- Proof of income
- Prescriber license number
- Either DEA or state license number
- Who can sign
- Physician
- Application can be faxed
- Yes
- Decision letter sent to
- Provider and patient
Getting the medication
- Patient receives
- Medication
- Shipped to
- Provider
- Supply per shipment
- 90-day supply
- Time to first delivery
- 3–4 weeks
- Refills
- Varies
- Staying enrolled
- New application every 12 months
- New proof of income every 12 months
Medications covered
- Abrysvo (Respiratory Syncytial Virus Vaccine)
- Adcetris (brentuximab vedotin)
- BeneFIX injection (recombinant)
- Besponsa (inotuzumab ozogamicin)
- Braftovi capsules (encorafenib)
- Celontin (methsuximide)
- Cibinqo (abrocitinib tablet)
- Comirnaty (COVID-19 Vaccine, mRNA)
- Daurismo (glasdegib sodium)
- Depo Estradiol (estrodiol cypionate in oil)
- Duavee Tablet (conjugated estrogens/bazedoxifene)
- Elelyso (taliglucerase alfa powder)
- Ellence (epirubicin hcl)
- Elrexfio (elranatamab-bcmm)
- Estring (estradiol vaginal ring)
- Eucrisa (crisaborole ointment)
- Hympavzi (marstacimab-hncq)
- Ibrance (palbociclib)
- Inlyta (axitinib)
- Litfulo (ritlecitinib)
- Lorbrena (lorlatinib)
- Mektovi tablets (binimetinib)
- Mylotarg (gemtuzumab)
- Ngenla (somatrogon-ghla)
- Norpace (disopyramide)
- Nurtec ODT (rimegepant)
- Paxlovid (Nirmatrelvir/ritonavir)
- Penbraya (Meningococcal Groups A, B, C, W, and Y Vaccine)
- Premarin (conjugated estrogens)
- Premphase (conjugated estrogens/medroxyprogesterone acetate tablets)
- Prempro (conjugated estrogens; medroxyprogesterone acetate)
- Prevnar 20 (pneumococcal 20-valent conjugate vaccine [Diphtheria CRM197 Protein])
- Somavert (pegvisomant)
- Sutent (sunitinib malate)
- Synarel (nafarelin acetate)
- Talzenna (talazoparib)
- Tikosyn (dofetilide)
- Tivdak (tisotumab vedotin-tftv)
- Trazimera (trastuzumab-qyyp)
- Trumenba (Meningococcal Group B Vaccine)
- Tukysa (tucatinib tablets)
- Velsipity (etrasimod)
- Vyndamax (tafamidis)
- Xalkori (crizotinib)
- Xyntha (antihemophiliam factor (recombinant))
- Zarontin (ethosuximide)
- Zavzpret (zavegepant)